Circulation

DECEMBER 17, 2024

However, the role of METTL4-mediated mitoepigenetic regulation in atherosclerosis is still unknown. We explored the mechanism of METTL4 involvement in atherosclerosis usingMettl4Mac-KO-Apoe-/-andMettl4MUT-Apoe-/-mice and cell models, as well as bone marrow transplantation.

Atherosclerosis 40

Atherosclerosis Transplant Plaque Pharmacology 40

Journal of the American Heart Association

JANUARY 12, 2024

BackgroundUltraviolet B (UV‐B) irradiation is an effective treatment for human cutaneous disorders and was shown to reduce experimental atherosclerosis by attenuating immunoinflammatory responses. Our findings indicate that a novel 282 nm UV‐B phototherapy could be an attractive approach to treat atherosclerosis.

Atherosclerosis 45

Atherosclerosis Plaque Aortic Technology 45

DAIC

JANUARY 23, 2024

Better reimbursement for hospitals leads to improved accessibility to this technology, which is a win for everyone involved, most notably patients.” HeartFlow remains dedicated to reshaping cardiovascular care and ensuring that hospitals have access to comprehensive, accurate, and efficient solutions in precision coronary care.

Reimbursement 105

Reimbursement Coronary Artery Disease CMS Technology 105

DAIC

FEBRUARY 13, 2024

According to the company, Earls is a leader within the field of radiology and specializes in applications of advanced imaging technologies in cardiovascular care. He is the author of over 150 articles, book chapters, abstracts and other publications on advanced imaging technologies. Earls, MD , Chief Medical Officer of Cleerly.

Coronary Artery Disease 103

Coronary Artery Disease Ischemia Atherosclerosis Cardiovascular Imaging 103

Science Daily - Heart Disease

SEPTEMBER 18, 2024

A team developed a nanoparticle technology that offers an effective solution to diagnose and treat atherosclerosis, in a non-invasive manner.

Atherosclerosis 113

Atherosclerosis Technology Research Plaque 113

DAIC

JULY 18, 2024

This registry will aim to provide world-wide physicians the most accurate information on coronary plaque to improve cardiovascular risk prediction and support the selection of patient-specific treatment,” said Dr. De Cecco. Márton Kolossváry (Gottsegen National Cardiovascular Center, Budapest, Hungary).

Plaque 105

Plaque Heart Attack Heart attacks Cardiovascular Disease 105

MIBHS

FEBRUARY 28, 2025

Specific genetic variants, such as those affecting cholesterol metabolism, can increase the likelihood of plaque buildup in the arteries. Inflammation: Genetic variations can make some people more prone to chronic inflammation, which contributes to the development of atherosclerosis.

Genetic predisposition 52

Genetic predisposition Heart Disease Cholesterol Blood Pressure 52